Invention Grant
- Patent Title: Use of an active substance in the treatment of melasma
-
Application No.: US16313526Application Date: 2017-06-28
-
Publication No.: US10744135B2Publication Date: 2020-08-18
- Inventor: Doris Maria Hexsel
- Applicant: Doris Maria Hexsel
- Agency: Lambert Shortell & Connaughton
- Agent Gary E. Lambert; David J. Connaughton, Jr.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4b4c1118 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1fdeb6df
- International Application: PCT/BR2017/050167 WO 20170628
- International Announcement: WO2018/000067 WO 20180104
- Main IPC: A61K31/498
- IPC: A61K31/498 ; A61K9/00 ; A61K8/02 ; A61K8/04 ; A61K8/49 ; A61P7/00 ; A61Q17/04 ; A61P17/00 ; A61K45/06
Abstract:
The present invention belongs, in a general manner to the technological field of the pharmaceutical industry and relates, more specifically, to one or more compositions of second use to be destined for the treatment of melasma. The present invention relates to the use of substances belonging to the group of alpha-adrenergic receptor agonists, in different variable concentrations, for treating conditions of melasma upon human skin. Furthermore, the present invention discloses pharmaceutical compositions, the latter being associated or not with other compounds or methods of treatment, to be utilised for the treatment of melasma.
Public/Granted literature
- US20190269680A1 USE OF AN ACTIVE SUBSTANCE IN THE TREATMENT OF MELASMA Public/Granted day:2019-09-05
Information query
IPC分类:
